Impact of metastasectomy on cancer specific and overall survival in metastatic renal cell carcinoma: Analysis of the REMARCC registry
Margaret Meagher(University of California San Diego), Ithaar Derweesh(Rush University Medical Center), Vital Hevia(Hospital Universitario Ramón y Cajal), Aaron Bradshaw(University of California San Diego), Estefanía Linares(Hospital Universitario La Paz), N. Pavan(University of Trieste), M. Albertsen(KU Leuven), M. D’Anna(Hospital Clínic de Barcelona), Michele Marchioni(University of Chieti-Pescara), Andrea Minervini(Azienda Ospedaliero-Universitaria Careggi), Riccardo Campi(University of Florence), M.C. Mir(Fundación Instituto Valenciano de Oncología), Riccardo Autorino(Rush University Medical Center), M. Kriegmair(Urologische Klinik München), Georgi Guruli(VCU Massey Comprehensive Cancer Center), Siska Van Bruwaene(AZ Groeninge), Mireía Musquera(Surgical Specialties (Canada)), Alessandro Antonelli(University of Verona), Fady Ghali(University of California San Diego), Francesco Claps(University of Trieste), Dev Patel, E. Rousel(University of California San Diego), J. Rubió, M. Heck(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Carlotta Palumbo(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”)
Cited by 2
Related Papers
Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer
|European Urology|2016|1.5k
Cardiovascular toxicity following sunitinib therapy in metastatic renal cell carcinoma: a multicenter analysis
|Annals of Oncology|2009|205
Renal Cell Carcinoma as a Metabolic Disease: An Update on Main Pathways, Potential Biomarkers, and Therapeutic Targets
|International Journal of Molecular Sciences|2022|190